Cargando…
Activity of a trinuclear platinum complex in human ovarian cancer cell lines sensitive and resistant to cisplatin: cytotoxicity and induction and gene-specific repair of DNA lesions
A collateral sensitivity or a very modest cross-resistance to BBR 3464 was found in 2 ovarian cancer cell lines with experimentally induced resistance to cisplatin. Loss of mismatch repair proteins (hMLH1, hPMS2) or overexpression of nucleotide excision repair proteins (ERCC1) was not detrimental fo...
Autores principales: | Colella, G, Pennati, M, Bearzatto, A, Leone, R, Colangelo, D, Manzotti, C, Daidone, M G, Zaffaroni, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363643/ https://www.ncbi.nlm.nih.gov/pubmed/11355952 http://dx.doi.org/10.1054/bjoc.2001.1751 |
Ejemplares similares
-
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999) -
Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
por: Zaffaroni, N., et al.
Publicado: (1998) -
Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres
por: Hamad, Shahnaz A, et al.
Publicado: (2014) -
Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin
por: O’Neill, C F, et al.
Publicado: (1999) -
Involvement of bcl-2 and p21(waf1) proteins in response of human breast cancer cell clones to Tomudex
por: Orlandi, L, et al.
Publicado: (1999)